Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D MORROW

Showing results (71-80 of 173) with videos related to

Pageof 18
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykininN J Brown, D Ryder, J V Gainer, et al.
Infection and Immunity|April 1, 1995
Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharideG I Pérez-Pérez, V L Shepherd, J D Morrow, et al.
Cancer Research|September 24, 1999
Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesisT O Daniel, H Liu, J D Morrow, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 1, 1993
Airway and vascular effects of 8-epi-prostaglandin F2 alpha in isolated perfused rat lungK H Kang, J D Morrow, L J Roberts, et al.
The American Journal of Physiology|September 1, 1992
Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situM Banerjee, K H Kang, J D Morrow, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growthC S Williams, A P Goldman, H Sheng, et al.
The New England Journal of Medicine|October 29, 1998
Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjectsJ V Gainer, J D Morrow, A Loveland, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 30, 2000
Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overloadK Chen, J Suh, A C Carr, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2000
Metabolism of bradykinin In vivo in humans: identification of BK1-5 as a stable plasma peptide metaboliteL J Murphey, D L Hachey, J A Oates, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 24, 2001
Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assayC R Morales, E S Terry, W E Zackert, et al.
Pageof 18

Showing results (71-80 of 173) with videos related to

Sort By:
Pageof 18
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykininN J Brown, D Ryder, J V Gainer, et al.
Infection and Immunity|April 1, 1995
Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharideG I Pérez-Pérez, V L Shepherd, J D Morrow, et al.
Cancer Research|September 24, 1999
Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesisT O Daniel, H Liu, J D Morrow, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 1, 1993
Airway and vascular effects of 8-epi-prostaglandin F2 alpha in isolated perfused rat lungK H Kang, J D Morrow, L J Roberts, et al.
The American Journal of Physiology|September 1, 1992
Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situM Banerjee, K H Kang, J D Morrow, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growthC S Williams, A P Goldman, H Sheng, et al.
The New England Journal of Medicine|October 29, 1998
Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjectsJ V Gainer, J D Morrow, A Loveland, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 30, 2000
Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overloadK Chen, J Suh, A C Carr, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2000
Metabolism of bradykinin In vivo in humans: identification of BK1-5 as a stable plasma peptide metaboliteL J Murphey, D L Hachey, J A Oates, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 24, 2001
Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assayC R Morales, E S Terry, W E Zackert, et al.
Pageof 18